The following technologies are available for licensing. Please do not hesitate to contact Lawrence Lau, Director of Industry Alliances & Commercialization at lalau@chapman.edu for more information.
|
Case Number |
Invention Title |
|
Rapid Selective Detection of Bacteria |
|
|
18-01 |
"Novel neuronal nitric oxide synthase (nNOS) inhibitors for the immunotherapy of human melanoma patients", joint invention with Northwestern University |
|
19-01 |
"Particles for Targeted Delivery and Uses in Managing Bleeding or Blood Clotting", joint invention with Emory University |
|
Targeting Primary Cilia with Nanoparticles |
|
|
Peptide/Lipid-Associated Nucleic Acids as a Multicomponent siRNA Delivery System |
|
|
Targeted Peptide-Drug Conjugates to Overcome Multi-Drug Resistance in Cancer |
|
| 2020-008 | Variable Light Diffuser for Plant Leaf Gas Exchange Measurements |
| 2020-009 | Targeting Polycystic Kidney Disease with Nanomedicines |
| 2022-002 | Bis-Cinnamamide Derivatives as Novel APE/Ref-1 Inhibitors for the Treatment of Human Melanoma |
|
SK Channel Positive Allosteric Modulators |
|
| 2022-003 | A Small Peptide Increases Drug Delivery in Human Melanoma Cells |
| 2022-004 | Enzymatic Break Down of Chlorogenic Acid in Sunflower Meal and Butter for Baking |
| 2023-005 |
Super Interferometric Range Resolution |
|
Biochemical Biomarkers for Kidney Diseases |
|
|
Low Power Latches for Different Precision Needs |